MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-DL-11-0016102
SMPL Life Sciences Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹194.66 Cr
▲ 6% YoY
Net profit · FY 2025
₹1.11 Cr
Net margin 0.6%
EBITDA · FY 2025
₹5 Cr
EBITDA margin 2.6%
Authorised capital
₹30 Lakh
Registered with MCA
Paid-up capital
₹30 Lakh
Issued & subscribed
Open charges
₹82.74 Cr
Satisfied ₹9.5 Cr
Company age
15 yrs
Est. 2011
Employees · EPFO
30
Provident fund records
About SMPL Life Sciences Private Limited
Data last updated:
SMPL Life Sciences Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 December 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2011PTC229383. Its GSTIN is 09AAQCS7546E1ZT (Uttar Pradesh). The company holds 6 GST registrations, all of them active.
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹30 Lakh. It is led by directors including Gaurav Sabharwal and Meenu Sabharwal.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 1003 – 1005 Vishal Tower District Centre Janak Puri, New Delhi, Delhi, India – 110058.
As per the financials filed for FY 2025, the company reported a revenue of ₹194.66 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹1.11 Cr (net margin 0.6%) and EBITDA of ₹5 Cr (EBITDA margin 2.6%). Revenue has grown at a compounded annual rate (CAGR) of 26% over three years and 24% over five years.
The company has about 30 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹82.74 Cr and satisfied charges of ₹9.5 Cr on record. Court records list 2 cases involving the company, including 2 filed against it. The company has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹29 Lakh; the latest was in March 2018. Its 5 peer companies in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 2 larger and 3 smaller; the largest is Umang Cure Private Limited with revenue of ₹203.3 Cr.
SMPL Life Sciences Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-11-0016102). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website smplgroup.org.
Company details
CIN U24232DL2011PTC229383
Registration Number 229383
Incorporation Date 28 December 2011
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-DL-11-0016102
Recognitions & Rankings of SMPL Life Sciences
Contact details
SMPL Life Sciences Private Limited's registered office is in New Delhi, Delhi. Its website is smplgroup.org. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address1003 – 1005 Vishal Tower District Centre Janak Puri, New Delhi, Delhi, India – 110058
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of SMPL Life Sciences Private Limited, buy the company report.
Comprehensive company report
SMPL Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of SMPL Life Sciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of SMPL Life Sciences Private Limited, buy the company report.
Financials of SMPL Life Sciences Private Limited
FY 2024 filings availableSMPL Life Sciences Private Limited reported revenue of ₹194.66 Cr (up 6% YoY) for FY 2025.
Revenue · FY 2025
₹194.66 Cr ▲ 6%
Net profit · FY 2025
₹1.11 Cr margin 0.6%
EBITDA · FY 2025
₹5 Cr margin 2.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 6%
3 years · compounded
▲ 26%
5 years · compounded
▲ 24%
EBITDA CAGR growth
1 year
▼ 36%
3 years · compounded
▼ 15%
5 years · compounded
▲ 1%
Revenue has grown at a compounded annual rate (CAGR) of 24% over five years, including 6% growth in the latest year. EBITDA fell 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.11 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.6% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of SMPL Life Sciences Private Limited, buy the company report.
Board of directors of SMPL Life Sciences Private Limited
SMPL Life Sciences has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gaurav Sabharwal | Director | 28 Dec 2011 | 14 Years 10 Months | Current |
| Meenu Sabharwal | Director | 28 Dec 2011 | 14 Years 10 Months | Current |
| Sarika Sabharwal Also directs: Sabharwal Medicos LLP, Alma Mater Agencies Private Limited | Director | 28 Dec 2011 | 14 Years 10 Months | Current |
Peer comparison
SMPL Life Sciences Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Umang Cure Private Limited | ₹203.3 Cr (FY 2025) | 14.0% | New Delhi, Delhi, India | |||
| Vasu Vaccines & Speciality Drugs Private Limited | ₹198.66 Cr (FY 2023) | 12.0% | Hyderabad, Telangana, India | |||
| SMPL Life Sciences Private Limitedthis company | ₹194.66 Cr (FY 2025) | ₹1.11 Cr | 0.6% | 6.0% | 30 | New Delhi, Delhi, India |
| Sood Medicine Traders Private Limited | ₹194.03 Cr (FY 2025) | 7.0% | Punjab, India | |||
| Livanova India Private Limited | ₹192.91 Cr (FY 2025) | 41.0% | Gurgaon, Haryana, India | |||
| Anm Pharma Private Limited | ₹190.81 Cr (FY 2025) | 3.0% | New Delhi, Delhi, India |
To see the full peer comparison of SMPL Life Sciences Private Limited, buy the company report.
Auditor
SMPL Life Sciences Private Limited is audited by J.S. SACHDEVA & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| J.S. SACHDEVA & CO. | FY 2023 | 017415N |
Shareholding
The shareholding of SMPL Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of SMPL Life Sciences Private Limited, buy the company report.
Charges & borrowings
Open charges
₹82.74 Cr
Satisfied charges
₹9.5 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 19 Mar 2025 | 101101666 | Others | ₹50 Lakh | Open | |
| 06 Sep 2024 | 100976451 | Axis Bank Limited | ₹1 Cr | Open | |
| 08 Apr 2024 | 100923599 | Others | ₹5 Cr | Open | |
| 07 Mar 2023 | 100687035 | Others | ₹4 Cr | Open | |
| 29 Sep 2021 | 100503314 | Hdfc Bank Limited | ₹1.84 Cr | Open |
To see the full charge records of SMPL Life Sciences Private Limited, buy the company report.
Total charge records: 9 View all charges
Deals & funding
SMPL Life Sciences Private Limited has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹29 Lakh; the latest was in March 2018.
Total deals
4
Secondary share transfers
3
Funding round
1
Disclosed funding
₹29 Lakh
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2018 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Nov 2017 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2014 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2013 | Funding round | ₹29 Lakh | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
SMPL Life Sciences Private Limited has 2 court cases on record: 2 filed against it. All cases are disposed.
Total cases
2
Filed against the company
2
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Faridabad, Haryana | Cheque dishonour complaint | Filed against the company by Glensmith Labs Pvt Ltd | Disposed |
| District court, South West, Delhi | Civil suit | Filed against the company by State | Disposed |
To see the full case history of SMPL Life Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
SMPL Life Sciences Private Limited was last rated by Crisil on 20 Aug 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 20 Aug 2020 |
To see the full credit ratings and regulatory alerts of SMPL Life Sciences Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for SMPL Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
SMPL Life Sciences Private Limited has a workforce of 30 employees on its EPFO records as of Mar 24, 2024, across 1 active EPFO establishment.
Employee count
30
Active EPFO establishments
1
Employee growth
25%
GST
SMPL Life Sciences has 6 GST registrations: 6 active. The first 4 active GSTINs are listed below.
Total GSTINs
6
Active
6
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAQCS7546E1ZT | Uttar Pradesh | Active | 01 Jul 2017 |
| 27AAQCS7546E1ZV | Maharashtra | Active | 01 Jul 2017 |
| 06AAQCS7546E1ZZ | Haryana | Active | 04 Jul 2019 |
| 29AAQCS7546E1ZR | Karnataka | Active | 30 Sep 2020 |
To see the full GST registrations and return filing status of SMPL Life Sciences Private Limited, buy the company report.
Recent activity
SMPL Life Sciences Private Limited has 5 board changes on record since 2011: 3 appointments and 2 cessations. The latest: Gaurav Sabharwal ceased to be Director on 16 Jun 2025.
Charges
A charge with Others of Rs. 5,000.00 Lakh registered on 14 Dec 2018 with Charge ID 100224837 was modified on 31 Jul 2025.
Ceased
Gaurav Sabharwal ceased to be Director.
Charges
A charge with Others of Rs. 499.90 Lakh registered on 08 Apr 2024 with Charge ID 100923599 was modified on 26 Mar 2025.
Charges
A charge with Others amounted to Rs. 50.00 Lakh with Charge ID 101101666 was registered on 19 Mar 2025.
AGM
Smpl Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge with Axis Bank Limited amounted to Rs. 100.00 Lakh with Charge ID 100976451 was registered on 06 Sep 2024.
Charges
A charge with Others amounted to Rs. 499.90 Lakh with Charge ID 100923599 was registered on 08 Apr 2024.
Filing
Smpl Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Charges
A charge with Others of Rs. 2,040.00 Lakh registered on 20 Mar 2021 with Charge ID 100435026 was modified on 19 Jun 2023.
Charges
A charge with Others amounted to Rs. 400.00 Lakh with Charge ID 100687035 was registered on 07 Mar 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 184.00 Lakh with Charge ID 100503314 was registered on 29 Sep 2021.
Charges
A charge with Others amounted to Rs. 2,040.00 Lakh with Charge ID 100435026 was registered on 20 Mar 2021.
12 earlier events are in the company report.
Frequently asked questions
SMPL Life Sciences is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 December 2011 (15+ years old) and is registered under CIN U24232DL2011PTC229383.
SMPL Life Sciences has 3 current directors:
- Gaurav Sabharwal - Director
- Meenu Sabharwal - Director
- Sarika Sabharwal - Director
The latest financial statements of SMPL Life Sciences on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of SMPL Life Sciences is 09AAQCS7546E1ZT, registered in Uttar Pradesh. The company has 6 GST registrations in all, of which 6 are active. Other active GSTINs include 27AAQCS7546E1ZV (Maharashtra), 06AAQCS7546E1ZZ (Haryana), 29AAQCS7546E1ZR (Karnataka).
The CIN (Corporate Identification Number) of SMPL Life Sciences is U24232DL2011PTC229383. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
SMPL Life Sciences has 2 court cases on record: 2 filed against it.
SMPL Life Sciences was incorporated on 28 December 2011, making it 15+ years old. It is registered with the Registrar of Companies, Delhi.
SMPL Life Sciences has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹29 Lakh; the latest was in March 2018.
The peers of SMPL Life Sciences by revenue are Umang Cure Private Limited, Vasu Vaccines & Speciality Drugs Private Limited, Sood Medicine Traders Private Limited, Livanova India Private Limited, Anm Pharma Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Gaurav Sabharwal ceased to be Director on 16 Jun 2025. Jetender Sabharwal ceased to be Additional Director on 17 Oct 2017. Gaurav Sabharwal was appointed as Director on 28 Dec 2011. SMPL Life Sciences has 5 board changes on record in total.
Yes, SMPL Life Sciences is registered as a medium enterprise under Udyam registration (number: UDYAM-DL-11-0016102).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages